Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Intraocular Lymphoma × Procarbazine × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 28 Hodgkin Disease 19 Recurrence 4 Neurotoxicity Syndromes 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Lymphoma, AIDS-Related 2 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Intraocular Lymphoma 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1

Interventions

Rituximab 15 Peripheral Blood Stem Cell Transplantation 13 Cyclophosphamide 12 fludarabine phosphate 11 Whole-Body Irradiation 9 Cyclosporine 9 Mycophenolic Acid 8 Filgrastim 8 Methotrexate 7 Lenalidomide 7 Etoposide 7 Tacrolimus 5 Radiotherapy 5 Dexamethasone 5 Cytarabine 5 Vorinostat 4 Therapeutics 4 Psychiatric Rehabilitation 4 Melphalan 4 Carboplatin 4 Antilymphocyte Serum 4 Thiotepa 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Dasatinib 3 Busulfan 3 Bortezomib 3 tanespimycin 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡